|
|
GE Healthcare announces U.S. FDA approval of macrocyclic MRI contrast agent Clariscan injection |
The U.S. FDA has approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio for U.S. patients...
|
|
|
Nevro Announces Launch of Senza Omnia Spinal Cord Stimulation System to Treat Chronic Pain |
Nevro Corp announced it has received approval from the U.S. FDA for the Senza Omnia Spinal Cord Stimulation System. The Omnia system is the first and SCS...
|
|